Morgan Stanley Downgrades Doximity to Underweight, Lowers Price Target to $29

Benzinga · 01/06/2023 12:30
Morgan Stanley analyst Ricky Goldwasser downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underweight and lowers the price target from $32 to $29.